Skip to main content
. 2009 Feb;4(2):316–322. doi: 10.2215/CJN.02580508

Table 2.

Clinical and laboratory characteristics of patients with and without coronary calcification (CAC)

Characteristic Without CAC With CAC P
No. of patients (%) 224 (57.7) 164 (42.3)
Male gender (%) 72.3 85.4 0.0022
Age > 65 yr old (%) 4.9 29.9 0.0000
Diabetes mellitus (%) 6.8 22.8 0.0001
GFR<60 ml/min (%) 44.5 61.6 0.0009
Hypertension (%) 78.6 92.0 0.0004
Pulse pressure ≥75th percentile (%) 31.4 50.7 0.0003
Fibrinogen ≥75th percentile (%) 19.0 32.7 0.01
hs-CRP ≥ 75th percentile (%) 23.8 28.9 NS
i-PTH above upper normal limit (%) 39.6 39.3 NS
Calcium above upper normal limit (%) 38.1 43.2 NS
Phosphorus above upper normal limit (%) 22.3 16.3 NS
Ca × P product above 55 mg2/dL2 (%) 5.7 4.9 NS
LDL-C above upper normal limit (%) 67.6 58.2 NS
Homocysteine ≥75th percentile (%) 24.8 25.3 NS

Fibrinogen 75th percentile value = 418 mg/dl; hs- CRP 75th percentile value = 0.4 mg/L; homocysteine 75th percentile value = 28.4 mg/L. Upper normal limit for i-PTH: 60 pg/ml for GFR ≥ 60 ml/min, 70 pg/ml for GFR range 59-30 ml/min, 110 pg/ml for GFR range 29-15 ml/min, and 300 pg/ml for GFR <15 ml/min. Upper normal limit for serum phosphorus: 4.6 mg/dl for GFR ≥15 ml/min and 5.5 mg/dl for GFR<15 ml/min. Upper normal limit for serum calcium:10.5 mg/dl for GFR ≥15 ml/min and 9.5 mg/dl for GFR <15 ml/min. LDL-C upper normal limit:100 mg/dl. GFR, glomerular filtration rate (as creatinine clearance); hs-CRP, high-sensitivity C-reactive protein; i-PTH, intact parathyroid hormone; Ca × P product, calcium–phosphorus product; LDL-C, low density lipoprotein-cholesterol.